Reproductive Medicine Unit, HUS
- Address
- Mannerheimintie 164a, 00300, Helsinki, Finland
Reproductive Medicine Unit, HUS
The Reproductive Medicine Unit at HUS is a specialized research center dedicated to advancing the understanding and treatment of reproductive endocrine disorders. The unit focuses on optimizing therapeutic interventions for women with hormonal imbalances and fertility challenges, conducting rigorous clinical trials to establish evidence-based treatment protocols.
- Polycystic ovary syndrome (PCOS) management and treatment optimization
- Metabolic interventions in reproductive endocrine disorders
- Pharmacological dose optimization studies for reproductive health
The center's research emphasizes personalized medicine approaches in reproductive endocrinology, particularly investigating optimal dosing strategies for metformin therapy in PCOS patients. Their work aims to balance treatment efficacy with patient safety and tolerability, focusing on both biochemical markers and clinical outcomes in women of reproductive age with metabolic and hormonal dysfunction.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1HUS-yhtymae1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 107 other sites in Finland
Therapeutic Area Benchmark — Finland
Select a therapeutic area to compare against other sites in Finland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Finland
Market Share
Country: Finland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Reproductive Medicine Unit, HUS
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial Evaluating Metformin and Metformin Hydrochloride Dosing in Overweight Adults with Polycystic Ovary Syndrome | HUS-yhtymae | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Metformin | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.